Skip to content
healthcare.dev

Cilostazol

NDC 70436-157, cilostazol, tablet, from Slate Run Pharmaceuticals, LLC.

Product NDC
70436-157
Status
Listed
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077208
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70436-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL100 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
70436-157-067043601570660 TABLET in 1 BOTTLE (70436-157-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db0278e9-4ece-4aaf-9216-6bcbec58206a
  • NADAC price for package 70436015706

    GET /v1/drugs/nadac/70436015706

Use it

Look up 70436-157 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70436-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70436-157. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.